Desyrel Desyrel is the brand name for the essential amino acid tryptophan. Once marketed as a prescription antidepressant, it is now primarily available as a dietary supplement and used anecdotally for mild depression, anxiety, and sleep disorders. — Mechanism of Action Serotonin precursor: Tryptophan is hydroxylated to 5‑hydroxytryptophan and decarboxylated to serotonin (5‑HT) in the … Read more
Desvenlafaxine Desvenlafaxine (brand name Pristiq) is a selective serotonin‑norepinephrine reuptake inhibitor (SNRI) used primarily for the treatment of major depressive disorder (MDD). The following drug card provides a concise, SEO‑friendly reference for students and clinicians. — Mechanism of Action Reuptake inhibition: Serotonin (5‑HT) transporter (SERT) – ~80 % of its effect. Norepinephrine transporter (NET) – ~20 % … Read more
Desloratadine Mechanism of Action Selective antagonist of peripheral H₁ histamine receptors – competitively blocks histamine‑mediated vasodilation, capillary permeability, and pruritus. High affinity (Ki ≈ 0.1 nM) with rapid onset (~30 min). Minimal CNS penetration → negligible sedation or anticholinergic side‑effects. Metabolized from loratadine by CYP3A4/5; the active metabolite (desloratadine) is 10‑fold more potent. Pharmacokinetics Parameter Typical Values (Adult) Absorption … Read more
Descovy Descovy is the brand name for the fixed‑dose combination of emtricitabine 200 mg and tenofovir alafenamide (TAF) 25 mg. It is approved by the FDA for HIV‑1 prevention in adults and adolescents ≥ 12 years, including use as oral pre‑exposure prophylaxis (PrEP) and for HIV treatment in combination regimens that do not contain a protease inhibitor. — Mechanism … Read more
Depakote Valproic acid (brand: Depakote) is a widely used antiepileptic and mood‑stabilizing agent. Mechanism of Action Increase GABA concentrations Inhibits GABA‑transaminase and GABA‑T-1 transporters → higher intracellular GABA, enhancing inhibitory neurotransmission. Block voltage‑gated Na⁺ channels Prolongs the inactivated state, reducing neuronal firing. Reduce glutamate activity Inhibits Ca²⁺ influx and 5‑HT release, normalizing excitatory tone. Modulate voltage‑gated … Read more
Denosumab Denosumab is a fully human monoclonal antibody that selectively targets the RANK ligand (RANK‑L), inhibiting osteoclastogenesis and bone resorption. It is a cornerstone anti‑resorptive agent used for osteoporosis, bone metastatic disease, and various bone‑related malignancies. Mechanism of Action Selective inhibition of RANK‑L: Binds with high affinity to RANK‑L, preventing it from interacting with its … Read more
Delzicol Delzicol is the branded oral solution of ondansetron, a selective 5‑hydroxytryptamine‑3 (5‑HT₃) receptor antagonist used to manage nausea and vomiting across a broad spectrum of clinical situations. Mechanism of Action Fast‑acting 5‑HT₃ blockade: Ondansetron competitively binds to central and peripheral 5‑HT₃ receptors, preventing serotonin‑induced activation of the vomiting centre in the medulla and the … Read more
Degarelix Degarelix is a non‑peptide GnRH (gonadotropin‑releasing hormone) antagonist used for androgen‑deprivation therapy in advanced prostate cancer. Mechanism of Action Competitive block of GnRH receptors in the pituitary Prevents LH and FSH release → ↓testosterone & estradiol Rapid suppression of testosterone within 24 h (median: 2 days) No flare reaction: unlike GnRH agonists, it doesn’t first stimulate … Read more
Decadron Decadron is the brand name for dexamethasone, a potent synthetic glucocorticoid with anti‑inflammatory, immunosuppressive, and anti‑emetic properties. — Mechanism of Action Glucocorticoid receptor agonist → Forms a complex that translocates to the nucleus. Transactivates anti‑inflammatory genes (e.g., lipocortin‑1, IL‑10). Transrepresses pro‑inflammatory genes (e.g., IL‑1β, IL‑6, COX‑2, TNF‑α) by inhibiting NF‑κB and AP‑1. Inhibits phospholipase … Read more
Dayvigo Dayvigo (vortioxetine) is a novel serotonin modulator and activator approved for the treatment of major depressive disorder (MDD) in adults. Mechanism of Action Dayvigo exerts its antidepressant effects through a multifaceted action on the serotonergic system: 5‑HT1A partial agonist – stimulates postsynaptic receptors, enhancing mood regulation. 5‑HT1B partial agonist – modulates presynaptic feedback to … Read more